Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?

From Iskomunidad
Revision as of 23:00, 9 November 2012 by Pasy (talk | contribs) (→‎Program)

An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"

10 December 2012 (Monday), 2pm
NIH Conference Room (map)
University of the Philippines - Manila

Webpage shortcut: goo.gl/xszDH

Online Registration. Please register asap, as seats are limited. Confirmation will be needed.

Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA

Organizers

  • PGC ELSI Program
  • UP Manila Research Ethics Board
  • UP Manila National Institutes of Health



Program

  • Welcome Remarks - Dr Vicente Y. Belizario (Executive Director, UP Manila National Institutes of Health)
  • Opening Remarks - Dr Carmencita David Padilla (PGC Executive Director)
  • "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?" - Dr Reidar K. Lie (Adjunct Research Fellow, US NIH)
  • "Reviewing Genetic and Genomic Research: Issues and Challenges" - Dr Leslie Michelle M. Dalmacio (UP Manila Research Ethics Board)
  • Reactor 1: Dr Filipinas Natividad (SLMC VP for Research and Biotechnology Division)
  • Reaction 2
  • Open Discussion
  • Closing Remarks



Inquiries

Please direct them to
psy@kssp.upd.edu.ph



See Also

“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center

Retrieved from "https://iskomunidad.upd.edu.ph/index.php?title=Disclosure_of_Disease_Risks_in_Genomic_Research:_Under_what_circumstances_should_(not)_genomic_researchers_disclose_results_about_disease_risks%3F&oldid=30328"